Understanding Late‐Onset Interstitial Lung Disease in Systemic Sclerosis: Implications for Clinical Practice and Trial Design

Disclosure Form Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.